State Street’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $63.5M | Buy |
4,526,937
+52,734
| +1% | +$739K | ﹤0.01% | 1557 |
|
2025
Q1 | $70M | Sell |
4,474,203
-476,522
| -10% | -$7.45M | ﹤0.01% | 1468 |
|
2024
Q4 | $69M | Sell |
4,950,725
-690,906
| -12% | -$9.62M | ﹤0.01% | 1554 |
|
2024
Q3 | $52.5M | Buy |
5,641,631
+506,788
| +10% | +$4.71M | ﹤0.01% | 1687 |
|
2024
Q2 | $47.8M | Sell |
5,134,843
-3,649,195
| -42% | -$33.9M | ﹤0.01% | 1702 |
|
2024
Q1 | $87M | Buy |
8,784,038
+7,258,993
| +476% | +$71.9M | ﹤0.01% | 1400 |
|
2023
Q4 | $4.93M | Sell |
1,525,045
-2,835,762
| -65% | -$9.16M | ﹤0.01% | 2950 |
|
2023
Q3 | $23.2M | Sell |
4,360,807
-865,202
| -17% | -$4.59M | ﹤0.01% | 2078 |
|
2023
Q2 | $49.8M | Buy |
5,226,009
+1,611,228
| +45% | +$15.4M | ﹤0.01% | 1683 |
|
2023
Q1 | $39.8M | Sell |
3,614,781
-64,604
| -2% | -$711K | ﹤0.01% | 1801 |
|
2022
Q4 | $54.5M | Buy |
3,679,385
+1,024,150
| +39% | +$15.2M | ﹤0.01% | 1571 |
|
2022
Q3 | $50.7M | Buy |
2,655,235
+1,258,810
| +90% | +$24.1M | ﹤0.01% | 1591 |
|
2022
Q2 | $29.8M | Buy |
1,396,425
+206,925
| +17% | +$4.41M | ﹤0.01% | 1966 |
|
2022
Q1 | $22.9M | Buy |
1,189,500
+69,194
| +6% | +$1.33M | ﹤0.01% | 2295 |
|
2021
Q4 | $23.2M | Buy |
1,120,306
+81,093
| +8% | +$1.68M | ﹤0.01% | 2373 |
|
2021
Q3 | $24.8M | Sell |
1,039,213
-113,269
| -10% | -$2.71M | ﹤0.01% | 2330 |
|
2021
Q2 | $31.5M | Buy |
1,152,482
+184,500
| +19% | +$5.03M | ﹤0.01% | 2194 |
|
2021
Q1 | $28M | Buy |
967,982
+128,960
| +15% | +$3.73M | ﹤0.01% | 2142 |
|
2020
Q4 | $23.6M | Buy |
839,022
+573,588
| +216% | +$16.1M | ﹤0.01% | 2141 |
|
2020
Q3 | $7.78M | Buy |
265,434
+78,854
| +42% | +$2.31M | ﹤0.01% | 2573 |
|
2020
Q2 | $5.64M | Buy |
186,580
+19,022
| +11% | +$575K | ﹤0.01% | 2698 |
|
2020
Q1 | $4.99M | Buy |
+167,558
| New | +$4.99M | ﹤0.01% | 2629 |
|